These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 28818206)

  • 1. Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
    Travers JG; Kamal FA; Valiente-Alandi I; Nieman ML; Sargent MA; Lorenz JN; Molkentin JD; Blaxall BC
    J Am Coll Cardiol; 2017 Aug; 70(8):958-971. PubMed ID: 28818206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
    Valiente-Alandi I; Potter SJ; Salvador AM; Schafer AE; Schips T; Carrillo-Salinas F; Gibson AM; Nieman ML; Perkins C; Sargent MA; Huo J; Lorenz JN; DeFalco T; Molkentin JD; Alcaide P; Blaxall BC
    Circulation; 2018 Sep; 138(12):1236-1252. PubMed ID: 29653926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Fibroblast GRK2 Deletion Enhances Contractility and Remodeling Following Ischemia/Reperfusion Injury.
    Woodall MC; Woodall BP; Gao E; Yuan A; Koch WJ
    Circ Res; 2016 Oct; 119(10):1116-1127. PubMed ID: 27601479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous adrenal and cardiac g-protein-coupled receptor-gβγ inhibition halts heart failure progression.
    Kamal FA; Mickelsen DM; Wegman KM; Travers JG; Moalem J; Hammes SR; Smrcka AV; Blaxall BC
    J Am Coll Cardiol; 2014 Jun; 63(23):2549-2557. PubMed ID: 24703913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure.
    Casey LM; Pistner AR; Belmonte SL; Migdalovich D; Stolpnik O; Nwakanma FE; Vorobiof G; Dunaevsky O; Matavel A; Lopes CM; Smrcka AV; Blaxall BC
    Circ Res; 2010 Aug; 107(4):532-9. PubMed ID: 20576935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule disruption of G protein βγ subunit signaling reprograms human macrophage phenotype and prevents autoimmune myocarditis in rats.
    Karuppagounder V; Bajpai A; Meng S; Arumugam S; Sreedhar R; Giridharan VV; Guha A; Bhimaraj A; Youker KA; Palaniyandi SS; Karmouty-Quintana H; Kamal F; Spiller KL; Watanabe K; Thandavarayan RA
    PLoS One; 2018; 13(7):e0200697. PubMed ID: 30024944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gβγ-independent recruitment of G-protein coupled receptor kinase 2 drives tumor necrosis factor α-induced cardiac β-adrenergic receptor dysfunction.
    Vasudevan NT; Mohan ML; Gupta MK; Martelli EE; Hussain AK; Qin Y; Chandrasekharan UM; Young D; Feldman AM; Sen S; Dorn GW; Dicorleto PE; Naga Prasad SV
    Circulation; 2013 Jul; 128(4):377-87. PubMed ID: 23785004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction.
    Schumacher SM; Gao E; Zhu W; Chen X; Chuprun JK; Feldman AM; Tesmer JJ; Koch WJ
    Sci Transl Med; 2015 Mar; 7(277):277ra31. PubMed ID: 25739765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity-induced cardiac lipid accumulation in adult mice is modulated by G protein-coupled receptor kinase 2 levels.
    Lucas E; Vila-Bedmar R; Arcones AC; Cruces-Sande M; Cachofeiro V; Mayor F; Murga C
    Cardiovasc Diabetol; 2016 Nov; 15(1):155. PubMed ID: 27832814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial Ablation of G Protein-Coupled Receptor Kinase 2 (GRK2) Decreases Ischemia/Reperfusion Injury through an Anti-Intrinsic Apoptotic Pathway.
    Fan Q; Chen M; Zuo L; Shang X; Huang MZ; Ciccarelli M; Raake P; Brinks H; Chuprun KJ; Dorn GW; Koch WJ; Gao E
    PLoS One; 2013; 8(6):e66234. PubMed ID: 23805205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis.
    Molkentin JD; Bugg D; Ghearing N; Dorn LE; Kim P; Sargent MA; Gunaje J; Otsu K; Davis J
    Circulation; 2017 Aug; 136(6):549-561. PubMed ID: 28356446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms.
    Brinks H; Boucher M; Gao E; Chuprun JK; Pesant S; Raake PW; Huang ZM; Wang X; Qiu G; Gumpert A; Harris DM; Eckhart AD; Most P; Koch WJ
    Circ Res; 2010 Oct; 107(9):1140-9. PubMed ID: 20814022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GRK2 inhibition in heart failure: something old, something new.
    Lymperopoulos A; Rengo G; Koch WJ
    Curr Pharm Des; 2012; 18(2):186-91. PubMed ID: 22229578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure.
    Raake PW; Vinge LE; Gao E; Boucher M; Rengo G; Chen X; DeGeorge BR; Matkovich S; Houser SR; Most P; Eckhart AD; Dorn GW; Koch WJ
    Circ Res; 2008 Aug; 103(4):413-22. PubMed ID: 18635825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies.
    Rudomanova V; Blaxall BC
    Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):1883-1892. PubMed ID: 28130200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia.
    Ciccarelli M; Chuprun JK; Rengo G; Gao E; Wei Z; Peroutka RJ; Gold JI; Gumpert A; Chen M; Otis NJ; Dorn GW; Trimarco B; Iaccarino G; Koch WJ
    Circulation; 2011 May; 123(18):1953-62. PubMed ID: 21518983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure.
    Bradley JM; Spaletra P; Li Z; Sharp TE; Goodchild TT; Corral LG; Fung L; Chan KWH; Sullivan RW; Swindlehurst CA; Lefer DJ
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H563-H570. PubMed ID: 29949382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion.
    Penela P; Inserte J; Ramos P; Rodriguez-Sinovas A; Garcia-Dorado D; Mayor F
    EBioMedicine; 2019 Oct; 48():605-618. PubMed ID: 31594751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase N promotes cardiac fibrosis in heart failure by fibroblast-to-myofibroblast conversion.
    Yoshida S; Yoshida T; Inukai K; Kato K; Yura Y; Hattori T; Enomoto A; Ohashi K; Okumura T; Ouchi N; Kawase H; Wettschureck N; Offermanns S; Murohara T; Takefuji M
    Nat Commun; 2024 Sep; 15(1):7638. PubMed ID: 39266515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.